Soluble ST2 (sST2) as potential marker for hepatic cystic echinococcosis activity - 20/03/20
, Jianbing Ding a, c, ⁎ Highlights |
• | IL-33 levels in the CE patients were significantly lower than the healthy control subjects. |
• | Serum sST2 levels were significantly higher in the CE patients than the healthy control subjects. |
• | sST2 had certain diagnostic value for the CE activity and could be used as a biomarker for diagnosing CE activity. |
Abstract |
Objectives |
this study aims to identify the potential marker for hepatic cystic echinococcosis (CE) activity.
Methods |
totally 97 CE patients and 47 health control (HC) subjects were included. Based on the ultrasound (US) images, CE patients were further categorized as active CE (ACE; 52 cases) and inactive CE (IACE; 45 cases). The sST2 and IL (interleukin)-33 levels were measured by enzyme-linked immunosorbent assay. Univariate, multivariate and subgroup analysis were performed. The relationship between sST2 and CE activity was analyzed by the smooth curve fitting. The receiver operating characteristic (ROC) curve analysis was also performed.
Results |
the serum sST2 level in the CE patients was significantly higher than the HC subjects. Moreover, there was significant difference in the serum sST2 level between the ACE and IACE group. However, no significant difference was observed in the IL-33 level between the ACE and IACE groups. Univariate analysis showed that CE activity was significantly correlated with the sST2 level when the sST2 was greater than 1496.6 pg/mL. Multivariable analysis after adjustment for potential confounding factors, and subgroup analysis showed that sST2 had independent effect on CE activity. ROC curve showed that sST2 could differentially diagnose CE activity at the cut-off value of 1246.550 pg/mL with an AUC of 0.770.
Conclusion |
the sST2 could be used as a biomarker for hepatic CE activity. High levels of sST2 suggest that the hepatic CE is more likely to be active. Our findings have important guiding significance for the diagnosis of CE activity and the choice of treatment methods.
Le texte complet de cet article est disponible en PDF.Keywords : Hepatic cystic echinococcosis (CE), Soluble ST2 (sST2), IL-33, Biomarker
Plan
Vol 80 - N° 4
P. 462-468 - avril 2020 Retour au numéro
Article précédent
- Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
- Robert Butcher, Becca Handley, Mackline Garae, Raebwebwe Taoaba, Harry Pickering, Annie Bong, Oliver Sokana, Matthew J Burton, Nuno Sepúlveda, Ana Cama, Richard Le Mesurier, Anthony W. Solomon, David Mabey, Fasihah Taleo, Rabebe Tekeraoi, Chrissy h Roberts
- Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV
- Rui Li, Songlin Qiao, Gaiping Zhang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?